Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Large Cap
WOCKPHARMA
₹1,902
₹1867.70
₹1909.20
₹1086.70
₹2422.30
Markets Today
Historical Performance
As of 25-08-2026 01:22, Wockhardt Ltd. share price today is ₹0, with a change of ₹-1886.30 (-100.00%) from the previous close of ₹1886.3. The stock opened at ₹1888 and traded between ₹1867.7 and ₹1909.2, with a total traded volume of 306988 shares. The company has a market capitalization of ₹30650.9 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹2422.3 and ₹1086.7, respectively.
Wockhardt Ltd. valuation metrics include a P/E ratio of 74.9, EPS of ₹13.12, and book value of ₹6.10. Profitability indicators show ROE of 4.31%. Wockhardt Ltd. has reported revenue of ₹3564 Cr and net profit of ₹409 Cr.
Wockhardt Ltd. technical indicators include Day RSI at 48.36, Day MFI at 33.03, Day ADX at 13.1. Additional indicators include Commodity Channel Index (CCI) at -68.2 and Williams %R at -71.61. Momentum indicators show Day MACD at -11.3, Day MACD Signal Line at 0.89, DayATR at 66.47. Rate of Change indicators for Wockhardt Ltd. include ROC125 at 35.1 and ROC21 at 1.98.
Exponential moving averages include EMA5 at ₹1867.8, EMA10 at ₹1885.1, EMA12 at ₹1890.1, EMA20 at ₹1900.2, EMA26 at ₹1901.4, EMA50 at ₹1873.6, EMA100 at ₹1772, EMA200 at ₹1639.4. Simple moving averages include SMA5 at ₹1860.3, SMA10 at ₹1883.5, SMA20 at ₹1921.2, SMA30 at ₹1905.9, SMA50 at ₹1918.1, SMA100 at ₹1742.8, SMA150 at ₹1605.9, SMA200 at ₹1547.6.
Support levels for Wockhardt are placed at First Support ₹1844.60, Second Support ₹1802.90, Third Support ₹1775.80. Resistance levels are seen at First Resistance ₹1913.40, Second Resistance ₹1940.50, Third Resistance ₹1982.20. Wockhardt Ltd. shareholding pattern shows promoter holding at 49.08%, FII holding at 7.23%, DII holding at 0%, public holding at 34.44%.
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 561 | 516 | 430 | 380 | 413 |
| Operating Expense | 403.08 | 355 | 317 | 267 | 282 |
| Operating Profit | 157.92 | 161 | 113 | 113 | 131 |
| Depreciation | 41 | 43 | 52 | 45 | 46 |
| Interest | 43 | 41 | 50 | 44 | 41 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 106.92 | 167 | 28 | 54 | 69 |
₹1902.00
↗ Bullish Moving Average
10
↘ Bearish Moving Average
6
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 49.1 | 49.1 | 49.1 | 49.1 | 49.1 | 49.1 |
| FII | 6.8 | 7.3 | 7.1 | 7 | 7.1 | 7.2 |
| DII | 10.6 | 11 | 11 | 10.6 | 11 | 9.3 |
| Public | 33.5 | 32.6 | 32.8 | 33.4 | 32.8 | 34.4 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 2.64 L | 5.85 L | 45.18% |
| Week | 2.6 L | 4.89 L | 53.23% |
| 1 Month | 3.04 L | 6.94 L | 43.86% |
| 6 Month | 4.4 L | 16.4 L | 26.82% |
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Consistent high performing stocks over Five Years
Mid-range Performer (DVM)
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over 1 Year
Growth Stars: Strongest Annual EPS Performers
Companies that saw improvement in net profits, operating profit margin and revenues in the most recent quarter
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Good quarterly growth in the recent results
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with decreasing Promoter pledge
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Top Gainers
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 17 Nov, 2016 | 10 | INTERIM | 19 Nov, 2016 | Equity Share |
| 13 Nov, 2014 | 20 | INTERIM | 15 Nov, 2014 | Equity Share |
| 17 Feb, 2014 | 5 | INTERIM | 19 Feb, 2014 | Equity Share |
| 07 Nov, 2013 | 5 | INTERIM | 08 Nov, 2013 | Equity Share |
| 22 Aug, 2013 | 5 | FINAL | Equity Share | |
| 17 Apr, 2008 | 2.5 | FINAL | Equity Share | |
| 26 Oct, 2007 | 8.75 | INTERIM | 29 Oct, 2007 | Equity Share |
| 22 Mar, 2007 | 5 | FINAL | 23 Mar, 2007 | Equity Share |
| 21 Jun, 2006 | 5 | FINAL | Equity Share | |
| 12 Apr, 2005 | 5 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,766 | ₹883.60 | ₹1,436.80 | ₹1,862 | ₹2,374.50 | ₹212.43 |
| % Change | 2.39% | 1.39% | -1.41% | -0.05% | -0.40% | -0.58% |
| Revenue TTM (₹ Cr) | ₹1,935.80 | ₹2,002.34 | ₹2,250.36 | ₹9,683.45 | ₹14,737.88 | ₹9,205.28 |
| Net Profit TTM (₹ Cr) | ₹288.22 | ₹575.94 | ₹361.74 | ₹1,011.39 | ₹2,042.67 | ₹-313.62 |
| PE TTM | 99.10 | 85.20 | 85.50 | 34.90 | 48.20 | -90.70 |
| 1 Year Return | 255.61 | 5.9 | 57.4 | 24.77 | -8.55 | 10.85 |
| ROCE | 24.32 | 27.56 | 18.38 | 25.65 | 14.32 | 2.29 |
Acutaas Chemicals Ltd.
₹ 3171.00
+0.06%
Gland Pharma Ltd.
₹ 2811.90
-0.26%
Laurus Labs Ltd.
₹ 1801.00
-0.06%
Alkem Laboratories Ltd.
₹ 5350.00
-0.93%
Biocon Ltd.
₹ 409.40
-1.48%
Divi's Laboratories Ltd.
₹ 8496.00
-1.17%
Granules India Ltd.
₹ 857.00
-0.13%
Ajanta Pharma Ltd.
₹ 3581.00
-1.62%
Zydus Lifesciences Ltd.
₹ 1103.80
-1.45%
Glenmark Pharmaceuticals Ltd.
₹ 2390.70
+3.14%
Aurobindo Pharma Ltd.
₹ 1608.00
-0.82%
Sun Pharmaceutical Industries Ltd.
₹ 1910.00
+0.40%
Neuland Laboratories Ltd.
₹ 22901.00
-1.72%
Ipca Laboratories Ltd.
₹ 1921.00
+0.51%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2930.00
+0.96%
Pfizer Ltd.
₹ 4886.00
-1.85%
Abbott India Ltd.
₹ 26450.00
+0.84%
Torrent Pharmaceuticals Ltd.
₹ 4886.50
-0.20%
Lupin Ltd.
₹ 2188.00
-0.63%
Dr. Reddy's Laboratories Ltd.
₹ 1190.00
+1.30%
Cipla Ltd.
₹ 1437.90
+0.40%
By signing up I certify terms, conditions & privacy policy